Velpatasvir

HEPATITIS C DIRECT ACTING ANTIVIRALS (DAA)

Division: Pharmacy Policy Subject: Prior Authorization Criteria Original Development Date: Original Effective Date: Revision Date: February 17, 2017

Procedures, programs and drugs you must precertify

Procedures, programs and drugs you must precertify Participating provider precertification list Starting November 1, 2018 Applies to 1,2,3,4,9

  Programs, Drug, Procedures, Programs and drugs you

PRODUCT MONOGRAPH INCLUDING PATIENT …

PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PrVIREAD (tenofovir disoproxil fumarate) tablets . 300 mg . Antiretroviral Agent . Gilead Sciences, Inc.

  Information, Product, Patients, Monographs, Medication, Including, Product monograph, Product monograph including patient, Including patient medication information

Addendum1 to The use of stems in the selection of ...

INN Working Document 18.430 28/02/2018 Addendum1 to "The use of stems in the selection of International Nonproprietary names (INN) for pharmaceutical